These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4713570)

  • 21. [The effect of drugs on peritoneal dialysis clearance].
    Djukanović Lj; Ikonomovski J; Milovanović D
    Srp Arh Celok Lek; 1984 Jan; 112(1):115-26. PubMed ID: 6505849
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T; Patlak CS
    Adv Perit Dial; 1995; 11():63-6. PubMed ID: 8534740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical aspects of high peritoneal permeability].
    Grzegorzewska AE; Mariak I
    Pol Arch Med Wewn; 2002 Dec; 108(6):1217-21. PubMed ID: 12687935
    [No Abstract]   [Full Text] [Related]  

  • 24. Measurement of peritoneal clearances in self-dialysis patients.
    Barbour GL; Joe C; Patterson RM
    J Lab Clin Med; 1979 Oct; 94(4):526-31. PubMed ID: 479664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of peritoneal mass transport by three-pore model in children.
    Schaefer F; Haraldsson B; Haas S; Simkova E; Feber J; Mehls O
    Kidney Int; 1998 Oct; 54(4):1372-9. PubMed ID: 9767558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal clearance of creatinine and inulin during dialysis in dogs: effect of splanchnic vasodilators.
    Felt J; Richard C; McCaffrey C; Levy M
    Kidney Int; 1979 Oct; 16(4):459-69. PubMed ID: 548592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis.
    Bazzato G; Fracasso A; Gambaro G; Baggio B
    Lancet; 1995 Sep; 346(8977):740-1. PubMed ID: 7658876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical guidelines for automated peritoneal dialysis.
    Sritippayawan S; Nilwarangkur S; Aiyasanon N; Jattanawanich P; Vasuvattakul S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S167-74. PubMed ID: 22043586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of scleroderma-related end-stage renal disease with automated peritoneal dialysis.
    Pavan M; Aiyangar A; Chaudhari A; Rajputh P; Ranganath R; Babulal SA
    Iran J Kidney Dis; 2010 Apr; 4(2):162-3. PubMed ID: 20404430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PERITONEAL-EXTRACORPOREAL RECIRCULATION DIALYSIS A TECHNIQUE FOR IMPROVING EFFICIENCY OF PERITONEAL DIALYSIS.
    SHINABERGER JH; SHEAR L; BARRY KG
    Invest Urol; 1965 May; 2():555-66. PubMed ID: 14283599
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D; Prejac M; Jeren-Struić B; Gudelj J; Kovarbasić B
    Lijec Vjesn; 1982; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relation between the protein loss and small solates transport on peritoneal dialysis].
    Liu FY; Duan SB; Ping YM
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):602-3. PubMed ID: 12516425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Salvia Miltiorrhiza injection relieves peritoneal dialysis solution-induced injuries of peritoneal structure and function in rats].
    Zhang D; Shu J; Wang Y
    Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):517-23. PubMed ID: 18471419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
    Drachman R; Niaudet P; Gagnadoux MF; Broyer M
    Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
    Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
    Nephron; 1979; 24(1):34-40. PubMed ID: 40148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1989; 46(5):440-7. PubMed ID: 2772244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
    Vega N; Fernandez A; Hortal L; Macias M; Rodriguez JC; Plaza C; Perdomo M; Vega R; Palop L
    Adv Perit Dial; 1992; 8():467-70. PubMed ID: 1361850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.